Pronóstico del mercado de partículas similares a virus de Asia Pacífico hasta 2028: impacto de COVID-19 y análisis regional por tipo de producto (hepatitis, cáncer/VPH y enfermedad de Gaucher), fuente (levadura, células de insectos, plantas y otros) y aplicación (vacunas) y Terapéutica)

Se espera que el mercado de partículas similares a virus en Asia Pacífico crezca de 1.018,83 millones de dólares estadounidenses en 2021 a 1.769,02 dólares estadounidenses. millones para 2028; se estima que crecerá a una tasa compuesta anual del 8,2 % entre 2021 y 2028.

Varios actores del mercado de la atención sanitaria y organizaciones de investigación participan activamente en la innovación y el desarrollo de productos. El uso de partículas similares a virus es un enfoque emergente utilizado en la industria biofarmacéutica. Como las partículas similares a virus carecen de contenido viral, son más fáciles de manejar que los componentes virales reales. Las VLP se pueden utilizar para ayudar en la administración de fármacos, la obtención de imágenes, la inmunoterapia y la teragnóstica. Por ejemplo, según un estudio publicado en el NCBI en junio de 2020, las VLP se pueden utilizar en forma de nanopartículas en aplicaciones como terapia fototérmica, imágenes PET y CT, portadores de agentes de contraste para resonancia magnética, imágenes ópticas, vacunas contra enfermedades inflamatorias y autoinmunes. inmunoterapia contra el cáncer y administración de fármacos de moléculas pequeñas (en la terapia contra el cáncer). Por lo tanto, se espera que estas aplicaciones potenciales de VLP brinden oportunidades de crecimiento a los actores del mercado durante el período de pronóstico.

Según el informe del Fondo Monetario Internacional (FMI). , se esperaba que el crecimiento en Asia Pacífico se mantuviera estancado en cero por ciento en 2020. Este fue el peor desempeño de crecimiento en casi 60 años que involucraron la crisis financiera global (4,7%) y la crisis financiera asiática (1,3%). Las revisiones a la baja fueron sustanciales, oscilando entre el 3,5% en el caso de Corea, pero parecieron gestionar la lenta propagación del coronavirus debido a los paros de producción prolongados y minimizados que representan el 9% en Australia, Nueva Zelanda y Tailandia. Estos países se vieron muy afectados por el cierre del turismo en todo el mundo y, en el caso de Australia, por los menores precios de las materias primas. La región de Asia Pacífico, donde actualmente se están desarrollando vacunas contra la COVID-19, incluye Corea del Sur, China, Japón, Tailandia y Vietnam. Entre ellos, China tiene 15 vacunas, India y Corea del Sur poseen tres vacunas, Japón tiene dos vacunas y Tailandia y Vietnam tienen una vacuna. Entre estas vacunas se incluyen diez vacunas inactivadas, seis vacunas de subunidades proteicas, siete vacunas de vectores virales y seis vacunas de ácido nucleico. Además, promover una vacuna segura, equitativa y eficaz es una máxima prioridad en la región de Asia Pacífico. Según el informe del Banco Asiático de Desarrollo, en diciembre de 2020, el Banco Asiático de Desarrollo (BAD) lanzó una iniciativa de vacunas de 9 mil millones de dólares con el Fondo de Acceso a Vacunas de Asia Pacífico (APVAX) que ofrecerá apoyo rápido y equitativo a los miembros en desarrollo. (PMD) para adquirir y entregar una vacuna COVID-19 eficaz y segura. A través de la vacunación, se puede romper la cadena de transmisión del virus, salvar vidas y mitigar el impacto negativo de la pandemia.

Con la nueva características y tecnologías, los proveedores pueden atraer nuevos clientes y ampliar su presencia en los mercados emergentes. Es probable que este factor impulse el mercado de partículas similares a virus de Asia Pacífico. Se espera que el mercado de partículas similares a virus de Asia Pacífico crezca a una buena tasa compuesta anual durante el período de pronóstico.

Ingresos del mercado de partículas similares a virus de Asia Pacífico y pronóstico hasta 2028 (millones de dólares estadounidenses)

Segmentación del mercado de partículas similares a virus de Asia Pacífico

Mercado de partículas similares a virus de Asia Pacífico: Por tipo de producto

Hepatitis
Cáncer/VPH
Enfermedad de Gaucher

Mercado de partículas similares a virus de Asia Pacífico: Por fuente

Levadura
Célula de insecto
Planta
Otros

Mercado de partículas similares a virus de Asia Pacífico: Por Aplicación

Vacunas
Terapéuticas

Mercado de partículas similares a virus de Asia Pacífico: Por país

Mercado de partículas similares a virus de Asia Pacífico: Empresas mencionadas

Merck & Co., Inc. ; &n bsp ;
GlaxoSmithKline plc.
Pfizer Inc. ; &n bsp ; ;
Sanofi ; ;
< span>Serum Institute of India Pvt. Limitado. Ltd.
BHARAT BIOTECH ; &n bsp ;
LG Chem ; ;
Wantai BioPharm

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Virus-like Particles Market – By Product Type

1.3.2 Asia Pacific Virus-like Particles Market – By Source

1.3.3 Asia Pacific Virus-like Particles Market – By Application

1.3.4 Asia Pacific Virus-like Particles Market – By Country

2. Asia Pacific Virus-like Particles Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Virus-like Particles Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Infectious Viral Diseases

5.1.2 Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2 Market Restraints

5.2.1 Reach of Alternative Technologies for Viral Vaccine Production

5.3 Market Opportunities

5.3.1 Growing Potential Applications in Therapeutics and Diagnostics

5.4 Future Trends

5.4.1 Steady Demand for Innovative and Effective Products

5.5 Impact Analysis

6. Asia Pacific Virus-like Particles Market Analysis

6.1 Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7. Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1 Overview

7.2 Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer/ Human Papillomavirus (HPV)

7.4.1 Overview

7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5 Gaucher Disease

7.5.1 Overview

7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Virus-like Particles Market Analysis – By Source

8.1 Overview

8.2 Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3 Yeast

8.3.1 Overview

8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4 Plant

8.4.1 Overview

8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5 Insect Cell

8.5.1 Overview

8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Virus-like Particles Market Analysis – By Application

9.1 Overview

9.2 Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4 Therapeutics

9.4.1 Overview

9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Virus-like Particles Market – Country Analysis

10.1 Overview

10.1.1 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1 Impact Assessment of COVID-19 Pandemic

12. Asia Pacific Virus-like Particles Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Merck & Co., Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 GlaxoSmithKline plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sanofi

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Wantai BioPharm

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Serum Institute of India Pvt. Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BHARAT BIOTECH

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 LG Chem

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1. Asia Pacific Virus-like particles Market Segmentation

Figure 2. Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3. Asia Pacific Virus-like Particles Market Overview

Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5. India to Show Significant Growth during Forecast Period

Figure 6. Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10. Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000